Delisted
No longer trades. Fund positions are valued at its last close, $84.95 on Aug 31, 2026. View SEC filing

CRINETICS PHARMACEUTICALS INC
CRNXHealthcare
CRNX (CRINETICS PHARMACEUTICALS INC) is held by 1 institutional investors as of Q3 2026. Top institutional shareholders: Glenmede Trust Co. N.A. ($604,841).
No verdict yet — fewer than 2 funds hold CRNX.
Top Holders
Fund ownership
Fund holdings as of
Funds holding1
Value of reported holdings$604,841
Funds buying / selling
Not available
Checking access…
Showing 1-20 of 146
1 / 8
| Insider | Trade | Traded |
|---|---|---|
| Kalofonos Isabel | Disp $142K | |
| Nichols Weston | Disp $1.4M | |
| Vivaldi Coelho Rogerio | Disp $1.1M | |
| Fust Matthew K | Disp $1.9M | |
| Betz Stephen F. | Disp $5.0M | |
| WIERENGA WENDELL | Disp $9.9M | |
| Schilke Tobin | Disp $676K | |
| Bedrosian Camille L | Disp $1.4M | |
| Okey Stephanie | Disp $544K | |
| Struthers Richard Scott | Disp $21.1M |
Loading Congress trades…
| Filer | Stake | Filed |
|---|---|---|
| Wellington Management Group LLP | 6.8% | |
| FMR LLC | 1.4% | |
| Farallon Capital Management, L.L.C. | 8.5% | |
| T. Rowe Price Associates, Inc. | 5.1% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 6.1% | |
| Wellington Management Group LLP | 7.8% | |
| Vanguard Capital Management | 5.2% | |
| The Vanguard Group | 0.0% | |
| Farallon Capital Partners, L.P. | 0.6% | |
| FMR LLC | 15.0% |
Continue exploring
Other Healthcare stocks held by institutions
456 holders · $264.6B
455 holders · $846.2B
442 holders · $208.3B
438 holders · $117B
437 holders · $430.7B
432 holders · $256.6B
425 holders · $314.1B
425 holders · $109.3B
418 holders · $123.6B
412 holders · $151.2B
Questions investors ask about CRNX
Who owns CRNX?
1 institutional investor held CRNX on September 30, 2026, led by Glenmede Trust Co. N.A. ($604,841).
How many hedge funds hold CRNX?
1 institutional investor reported CRNX in their 13F filings for the quarter ended September 30, 2026, $604,841 in all.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer